One study has demonstrated that early monoclonal protein (M protein) decline pattern is an independent prognostic factor in patients with multiple myeloma (39), and we found that the bone marrow BCMA expression was moderately positively correlated with serum M protein (P=0.000, r=0.539). This evidence concerns the gene MYOM2 and plasma cell myeloma.